Aferrix is an innovative leader in development and applications of novel tools for early diagnosis and monitoring of toxic iron in the serum. The company has developed several methods that quantify different forms of toxic iron in the serum, which are not detected by conventional tests. Aferrix offers iron testing services and kits for research and treatment centers that specialize in iron over load diseases (Thalassemia, Hemochromatosis, Myelodysplastic syndrome) and to pharmaceutical companies that are developing iron chelators. The company was founded by Prof. Zvi Ioav Cabantchik, Department of Biological Chemistry, Alexander Silberman Institute of Life Sciences, Hebrew University of Jerusalem, Jerusalem, Israel.
| Website | https://www.aferrix.com/ |
| Revenue | $4 million |
| Employees | 2 (0 on RocketReach) |
| Founded | 2002 |
| Address | 19a Habarzel St Ramat Hachayal, Tel Aviv, Tel Aviv, IL |
| Technologies |
JavaScript
,
PHP
,
Google Analytics
+4 more
(view full list)
|
| Industry | Medical Equipment Manufacturing, Business Services General, Diagnostic Equipment, Business Services, Monitoring Equipment |
| Keywords | In Vitro Diagnostics, Diagnostic Tools, Medical Diagnostics, Clinical Diagnostics, Disease Monitoring, Health Diagnostics, Biomarker Discovery, Toxicology Testing, Hematology Testing, Precision Medicine |
| Competitors | Microsoft, SAP, IBM, Domo, Tableau, Qlik, Oracle, BankOne, Looker, Sisense +39 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 541713 Companies, NAICS Code 54 Companies |
Looking for a particular Aferrix employee's phone or email?
Aferrix Questions
The Aferrix annual revenue was $4 million in 2026.
Aferrix is based in Tel Aviv, Tel Aviv.
The NAICS codes for Aferrix are [54171, 5417, 541, 541713, 54].
The SIC codes for Aferrix are [87, 873].
